A new research study presented at the Digestive Disease Week meeting in San Diego found that a medicine called AT-1001 may protect celiac disease patients from exposure to gluten by preventing gluten from crossing the intestinal mucosa.
A new research study presented at the Digestive Disease Week meeting in San Diego found that a medicine called AT-1001 may protect celiac disease patients from exposure to gluten by preventing gluten from crossing the intestinal mucosa. In a second study at the meeting, researchers concluded that the current criteria for diagnosing celiac is too stringent, resulting in many patients going undiagnosed and untreated.
www.washingtonpost.com/wp-dyn/content/article/2008/05/19/AR2008051901173.html
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to